TEVA <TEVIY> SELLS PROMEDICO SUBSIDIARY Teva Pharmaceutical Industries Ltd, based in Israel, said it sold its wholly owned Promedico subsidiary, to foreign investors for four mln dlrs. It said the book value of the unit is about 2.2 mln dlrs. Teva said it will continue to market Promedico's products through its wholly owned subsidiary, Salomon, Levin and Elstein Ltd.